Effect of intermittent postoperative drain irrigation on time to functional recovery (TFR) following pancreatoduodenectomy (PD): The MARTINI Trial – A Randomized Controlled Trial.

Organizational Data

DRKS-ID:
DRKS00025073
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2021-06-15
Last update in DRKS:
2023-01-27
Registration type:
Prospective

Acronym/abbreviation of the study

MARTINI

URL of the study

No Entry

Brief summary in lay language

Regardless of improvements in surgical technique and perioperative management, complications after pancreatic surgery are relevant issues in abdominal surgery. The occurrence of pancreatic fistula is of central importance for the time to functional recovery (TFR) of the patients. Complications following pancreatic fistula are various and associated with a higher postoperative morbidity and mortality. In pancreatic surgery a surgical drain is placed adapted to the risk of the occurrence of pancreatic fistula at the end of the surgical operation. It is used postoperatively to evacuate intra-abdominal fluids. Super infected intraabdominal fluids are routinely evacuated and irrigated via the intraoperatively placed drains with saline solution. The usage of a surgical drain with preventive intermittent irrigation and the evacuation of potentially harmful fluids could decrease TFR in patients undergoing elective pancreatoduodenectomy. Furthermore the complications of pancreatic fistula and the overall morbidity of these patients could decrease and therefore quality of life could be improved. Aim of this trial is to determine whether the TFR can be reduced by usage of a surgical drain with preventive intermittent irrigation compared to the standard of care. Therefore in one group a surgical drain will be placed without using it for concomitant irrigation, while the other group will receive intermittent postoperative irrigation.

Brief summary in scientific language

Postoperative pancreatic fistula has been and is still the defining complication and challenge since the beginning of pancreatic surgery. Its occurrence is the largest contributor to major morbidity and mortality and may lead to a variety of additional complications and prolonged recovery. The placement of a surgical drain is standard operating procedure in pancreatic head resection. As well as using the drain for irrigation in case of suspected or proven intra-abdominal infection. The usage of a surgical drain with intermittent irrigation after pancreatoduodenectomy could decrease time to functional recovery (TFR) and reduce complications. In this prospective superiority study with an experimental parallel group design and equal allocation, two randomized controlled arms are used to determine whether TFR can be reduced by usage of a surgical drain compared to the standard of care with drain placement but without concomitant active intermittent irrigation. While the primary endpoint is TFR, the effect of active drain usage on the development of a clinically relevant postoperative pancreatic fistula, postoperative complications and associated costs, a set of general and surgical variables as well as patient reported outcomes will be analysed to evaluate efficacy of both methods.

Health condition or problem studied

Free text:
Patients scheduled for elective pancreatoduodenectomy
ICD10:
C25.0 - Head of pancreas
ICD10:
D37.70
ICD10:
D37.6 - Liver, gallbladder and bile ducts
ICD10:
K86.1 - Other chronic pancreatitis
ICD10:
K86.2 - Cyst of pancreas
ICD10:
K86.3 - Pseudocyst of pancreas
ICD10:
C24.0 - Extrahepatic bile duct
ICD10:
C24.1 - Ampulla of Vater
ICD10:
D13.2 - Duodenum
ICD10:
D13.6 - Pancreas
ICD10:
D13.7 - Endocrine pancreas
ICD10:
C17.0 - Duodenum
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Control group - Pancreatoduodenectomy according to the standard of care (drain will only be used for drainage and will not be used for irrigation)
Arm 2:
Experimental group - Pancreatoduodenectomy according to the standard of care and intervention via intermittent postoperative drain irrigation

Endpoints

Primary outcome:
Time to functional recovery (TFR) Time to functional recovery [days]. Functional recovery is assumed when all of the following conditions are fulfilled at the same time: 1. Adequate pain control with oral analgesia only (no need of intravenous (i.v.) or epidural analgesia and Numeric Rating Scale (NRS) ≤3); 2. Tolerance of solid food (oral intake of solid food is resumed and continued for at least 24 hours without vomiting); 3. Absence of intravenous fluids administration; 4. Independent mobility or mobility at the preoperative level [Postoperative Mobility Scale (PMS)]; 5. No signs of active abdominal infection [in case of suspected or confirmed abdominal infection this item is fulfilled when the patient has no fever (<38.5°C) and serum C-reactive protein concentration is decreasing and below 150mg/L]. The evaluation of time to functional recovery will start on POD 2 and will be assessed daily until discharge. It will be assessed whether or not if patients reach TFR until POD 90 or not. TFR will be counted as 90 days in case of death before reaching TFR.
Secondary outcome:
• Drain management and fluid contamination • Clinically relevant postoperative pancreatic fistulas (CR-POPF) • Delayed gastric emptying (DGE) (ISGPS definition) • Postpancreatectomy hemorrhage (PPH) • Health-related quality of life • Perioperative morbidity and mortality according to Clavien-Dindo classification at 90 days (±7 days) respectively comprehensive complication index (CCI) with focus on overall rate of Clavien-Dindo grade III or higher

Study Design

Purpose:
Treatment
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
No
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Chirurgische Klinik Mannheim

Recruitment period and number of participants

Planned study start date:
2021-09-20
Actual study start date:
2021-09-20
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
100
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
• Age equal to or greater than 18 years • elective open or minimally invasive pancreatoduodenectomy • Ability to understand the character and individual consequences of the clinical trial • Written informed consent

Exclusion Criteria

• Significant cardiac or respiratory failure (ASA >3) • Impaired mental state or incompetence of understanding the German language (no fluent German language speaker) • Expected lack of compliance • Participation in another study with interference of primary outcome

Addresses

Primary Sponsor

Address:
Universitätsmedizin Mannheim - Chirurgische Klinik
Theodor-Kutzer- Ufer 1-3
68167 Mannheim
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Universität Heidelberg, Medizinische Fakultät Mannheim, Chirurgische Klinik
Prof. Dr. med. Nuh N. Rahbari
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
+49621-383-2225
Fax:
-
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.umm.de/chirurgische-klinik/

Contact for Public Queries

Address:
Universität Heidelberg, Medizinische Fakultät Mannheim, Chirurgische Klinik
Prof. Dr. med. Nuh N. Rahbari
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
+49621-383-2225
Fax:
-
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.umm.de/chirurgische-klinik/

Principal Investigator

Address:
Universität Heidelberg, Medizinische Fakultät Mannheim, Chirurgische Klinik
Prof. Dr. med. Nuh N. Rahbari
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
+49621-383-2225
Fax:
-
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.umm.de/chirurgische-klinik/

Other contact for public queries

Address:
Universität Heidelberg, Medizinische Fakultät Mannheim, Chirurgische Klinik
PD Dr. med. Patrick Téoule
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
+49621383-2225
Fax:
-
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Universitätsmedizin Mannheim - Chirurgische Klinik
Theodor-Kutzer- Ufer 1-3
68167 Mannheim
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Medizinische Ethik-Kommission II Medizinischen Fakultät Mannheim, Forschungsgebäude, Haus 42 - Ebene 3
Theodor-Kutzer-Ufer 1-3
68167 Mannheim
Germany
Telephone:
+49-621-38371770
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2021-04-27
Ethics committee number:
2021-565
Vote of the Ethics Committee:
Approved
Date of the vote:
2021-06-07

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry